Development of Immunotherapy Combination Strategies in Cancer von Yap, Timothy A., Parkes, Eileen E., Peng, Weiyi, Moyers, Justin T., Curran, Michael A., Tawbi, Hussein A.

Volltext

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial von Tawbi, Hussein A, Burgess, Melissa, Bolejack, Vanessa, Van Tine, Brian A, Schuetze, Scott M, Hu, James, D'Angelo, Sandra, Attia, Steven, Riedel, Richard F, Priebat, Dennis A, Movva, Sujana, Davis, Lara E, Okuno, Scott H, Reed, Damon R, Crowley, John, Butterfield, Lisa H, Salazar, Ruth, Rodriguez-Canales, Jaime, Lazar, Alexander J, Wistuba, Ignacio I, Baker, Laurence H, Maki, Robert G, Reinke, Denise, Patel, Shreyaskumar

Volltext

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain von Tawbi, Hussein A, Forsyth, Peter A, Algazi, Alain, Hamid, Omid, Hodi, F. Stephen, Moschos, Stergios J, Khushalani, Nikhil I, Lewis, Karl, Lao, Christopher D, Postow, Michael A, Atkins, Michael B, Ernstoff, Marc S, Reardon, David A, Puzanov, Igor, Kudchadkar, Ragini R, Thomas, Reena P, Tarhini, Ahmad, Pavlick, Anna C, Jiang, Joel, Avila, Alexandre, Demelo, Sheena, Margolin, Kim

Volltext

The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition von Kreidieh, Firas Y., Tawbi, Hussein A.

Volltext

Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma von TARHINI, Ahmad A, CHERIAN, John, MOSCHOS, Stergios J, TAWBI, Hussein A, YONGLI SHUAI, GOODING, William E, SANDER, Cindy, KIRKWOOD, John M

Volltext

Circulating Tumor Cells and Early Relapse in Node-positive Melanoma von Lucci, Anthony, Hall, Carolyn S., Patel, Sapna P., Narendran, Boomadevi, Bauldry, Jessica B., Royal, Richard E., Karhade, Mandar, Upshaw, Joshua R., Wargo, Jennifer A., Glitza, Isabella C., Wong, Michael K. K., Amaria, Rodabe N., Tawbi, Hussein A., Diab, Adi, Davies, Michael A., Gershenwald, Jeffrey E., Lee, Jeffrey E., Hwu, Patrick, Ross, Merrick I.

Volltext

The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022 von Ascierto, Paolo A, Blank, Christian, Eggermont, Alexander M, Garbe, Claus, Gershenwald, Jeffrey E, Hamid, Omid, Hauschild, Axel, Luke, Jason J, Mehnert, Janice M, Sosman, Jeffrey A, Tawbi, Hussein A, Mandalà, Mario, Testori, Alessandro, Caracò, Corrado, Osman, Iman, Puzanov, Igor

Volltext

The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition von Anzar, Irantzu, Malone, Brandon, Samarakoon, Pubudu, Vardaxis, Ioannis, Simovski, Boris, Fontenelle, Hugues, Meza-Zepeda, Leonardo A, Stratford, Richard, Keung, Emily Z, Burgess, Melissa, Tawbi, Hussein A, Myklebost, Ola, Clancy, Trevor

Volltext

High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute von Davar, Diwakar, Ding, Fei, Saul, Melissa, Sander, Cindy, Tarhini, Ahmad A, Kirkwood, John M, Tawbi, Hussein A

Volltext

The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021 von Ascierto, Paolo A, Warner, Allison Betof, Blank, Christian, Caracò, Corrado, Demaria, Sandra, Gershenwald, Jeffrey E, Khushalani, Nikhil I, Long, Georgina V, Luke, Jason J, Mehnert, Janice M, Robert, Caroline, Rutkowski, Piotr, Tawbi, Hussein A, Osman, Iman, Puzanov, Igor

Volltext

A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma von Shou, Yaping, Robinson, Douglas M, Amakye, Dereck D, Rose, Kristine L, Cho, Yoon-Jae, Ligon, Keith L, Sharp, Thad, Haider, Asifa S, Bandaru, Raj, Ando, Yuichi, Geoerger, Birgit, Doz, François, Ashley, David M, Hargrave, Darren R, Casanova, Michela, Tawbi, Hussein A, Rodon, Jordi, Thomas, Anne L, Mita, Alain C, MacDonald, Tobey J, Kieran, Mark W

Volltext

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma von Tawbi, Hussein A, Schadendorf, Dirk, Lipson, Evan J, Ascierto, Paolo A, Matamala, Luis, Castillo Gutiérrez, Erika, Rutkowski, Piotr, Gogas, Helen J, Lao, Christopher D, De Menezes, Juliana Janoski, Dalle, Stéphane, Arance, Ana, Grob, Jean-Jacques, Srivastava, Shivani, Abaskharoun, Mena, Hamilton, Melissa, Keidel, Sarah, Simonsen, Katy L, Sobiesk, Anne Marie, Li, Bin, Hodi, F. Stephen, Long, Georgina V

Volltext

Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma von Eriksson, Hanna, Hansson, Johan, Krynitz, Britta, Masucci, Giuseppe, Girnita, Ada, Lapins, Jan, Huen, Auris O., Tawbi, Hussein A., Davies, Michael A., Tetzlaff, Michael T., Curry, Jonathan L.

Volltext

The "Great Debate" at Melanoma Bridge 2020: December, 5th, 2020 von Ascierto, Paolo A., Atkins, Michael B., Eggermont, Alexander M., Gershenwald, Jeffrey E., Grob, Jean-Jacques, Hamid, Omid, Sondak, Vernon K., Sosman, Jeffrey A., Tawbi, Hussein A., Weber, Jeffrey S., Caraco, Corrado, Osman, Iman, Puzanov, Igor

Volltext

Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (C... von Tawbi, Hussein A, Robert, Caroline, Brase, Jan C, Gusenleitner, Daniel, Gasal, Eduard, Garrett, James, Savchenko, Alexander, Görgün, Güllü, Flaherty, Keith T, Ribas, Antoni, Dummer, Reinhard, Schadendorf, Dirk, Long, Georgina V, Nathan, Paul D, Ascierto, Paolo A

Volltext

The efficacy of anti‐programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma von Ogata, Dai, Haydu, Lauren E., Glitza, Isabella C., Patel, Sapna P., Tawbi, Hussein A., McQuade, Jennifer L., Diab, Adi, Ekmekcioglu, Suhendan, Wong, Michael K., Davies, Michael A., Amaria, Rodabe N.

Volltext

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma von Butterfield, Lisa H, Vujanovic, Lazar, Santos, Patricia M, Maurer, Deena M, Gambotto, Andrea, Lohr, Joel, Li, Chunlei, Waldman, Jacob, Chandran, Uma, Lin, Yan, Lin, Huang, Tawbi, Hussein A, Tarhini, Ahmad A, Kirkwood, John M

Volltext

The great debate at "Melanoma Bridge 2018", Naples, December 1st, 2018 von Ascierto, Paolo A, Bruzzi, Paolo, Eggermont, Alexander, Hamid, Omid, Tawbi, Hussein A, van Akkooi, Alexander, Testori, Alessandro, Caracò, Corrado, Puzanov, Igor, Perrone, Francesco

Volltext

B cells are associated with survival and immunotherapy response in sarcoma von Petitprez, Florent, de Reyniès, Aurélien, Keung, Emily Z., Chen, Tom Wei-Wu, Sun, Cheng-Ming, Calderaro, Julien, Jeng, Yung-Ming, Hsiao, Li-Ping, Lacroix, Laetitia, Bougoüin, Antoine, Moreira, Marco, Lacroix, Guillaume, Natario, Ivo, Adam, Julien, Lucchesi, Carlo, Laizet, Yec′han, Toulmonde, Maud, Burgess, Melissa A., Bolejack, Vanessa, Reinke, Denise, Wani, Khalid M., Wang, Wei-Lien, Lazar, Alexander J., Roland, Christina L., Wargo, Jennifer A., Italiano, Antoine, Sautès-Fridman, Catherine, Tawbi, Hussein A., Fridman, Wolf H.

Volltext

Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic... von Saberian, Chantal, Amaria, Rodabe N., Najjar, Amer M., Radvanyi, Laszlo G., Haymaker, Cara L., Forget, Marie-Andrée, Bassett, Roland L., Faria, Silvana C., Glitza, Isabella C., Alvarez, Enrique, Parshottam, Sapna, Prieto, Victor, Lizée, Gregory, Wong, Michael K., McQuade, Jennifer L., Diab, Adi, Yee, Cassian, Tawbi, Hussein A., Patel, Sapna, Shpall, Elizabeth J., Davies, Michael A., Hwu, Patrick, Bernatchez, Chantale

Volltext